Fluorine-rich N-heterocyclic carbene–phosphorus pentafluoride (NHC-PF5) adducts proposed as thermally stable, potentially safer alternatives to fluorocarbon materials such as PTFE. These zwitterionic compounds are designed to deliver high surface energy, antifouling behavior, and lubricity for use as Teflon replacements, mold release agents, and self-assembled surface coatings.
NHC-PF5 adducts are a class of fluorine-rich compounds built from N-heterocyclic carbene (NHC) donors bonded to phosphorus pentafluoride (PF5) accepters. The resulting zwitterionic materials are designed to combine the desirable bulk properties of fluorocarbons—such as high surface energy, lubricity, and antifouling behavior—with improved thermal stability and degradation products that are expected to be benign to human health. Potential applications include Teflon replacements in industrial and consumer settings, mold release agents for manufacturing, and surface coatings where resistance to fouling and easy release are critical.
The work is at an early-to-mid stage of development. The research team has already established an efficient synthetic method for novel imidazolium and triazolium-based PF5 adducts, and select NHC-PF5 compounds have been reported in the literature. Future validation efforts will focus on preparing solution-processible thermoplastic polymers, thermosetting resins, and self-assembled monolayers containing NHC-PF5 groups, then characterizing their surface energy, lubricity, antifouling behavior, and stability to evaluate their potential as Teflon replacements. Funding is sought to support key personnel, chemicals and consumables, and materials testing.
UC San Diego is a comprehensive public research university in La Jolla, anchored by an integrated academic health system. On the east campus, the 23‑acre Science Research Park co‑locates corporate R&D with university programs and connects to the health sciences district, enabling daily interaction among scientists, clinicians, and companies. The Jacobs School’s Corporate Affiliates Program provides structured engagement and recruiting, while the Office of Innovation & Commercialization supports IP, licensing, and startup formation. The research enterprise is sustained by competitive federal funding, with recent awards exceeding $1.7B annually. Established commercialization pathways streamline sponsored research and help partners move from proof of concept to deployment.